Azurette Kit
Product Images NDC 51862-890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Azurette (NDC 51862-890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Desogestrel ethinyl estradiol is a combination of two hormones used as a birth control pill. It contains a progestin and an estrogen named desogestrel and ethinyl estradiol respectively. This medication works by preventing the release of eggs from the ovaries (ovulation). Additionally, it changes the cervical mucus and the lining of the uterus, making it difficult for sperm to enter the uterus or for a fertilized egg to attach to the uterus. The image provided seems to show the chemical structure of one of the hormones in the medication.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
Cigarette smoking and oral contraceptive use are risky, especially for women over 35 years old. Heavy smoking or smoking 15 or more cigarettes per day increases the risk of serious cardiovascular side effects. Women who use oral contraceptives are strongly advised not to smoke.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
This table presents circulatory disease mortality rates per 100,000 woman-years categorized by age, smoking status, and oral contraceptive use. The table compares ever-users (non-smokers and smokers) to controls (non-smokers and smokers). The data is adapted from a reference by P.M. Layde and V. Beral, denoted as #12.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
Cigarette smoking and oral contraceptive use can increase the risk of cardiovascular side effects, particularly in women over 35 years of age and those who smoke heavily (15 or more cigarettes per day). It is recommended that women who use oral contraceptives should not smoke.*
FDA Label Image

Image-05 (Image 05)

FDA Label Image

Image-06 (Image 06)

FDA Label Image

Image-07 (Image 07)

Image-07 (Image 07)
Cigarette smoking can increase the risk of serious cardiovascular problems in women who are taking oral contraceptives. The risk is higher in older women and those who smoke heavily (15 or more cigarettes per day), especially for those over 35 years old. As a cautionary measure, it is strongly advised that women who use oral contraceptives should not smoke.*
FDA Label Image

Image-08 (Image 08)

FDA Label Image

Image-09 (Image 09)

FDA Label Image

Image-10 (Image 10)

Image-10 (Image 10)
AzuretteĀ® is a medication that is used for oral contraception. This product contains Desogestrel and Ethinyl Estradiol Tablets, USP and Ethinyl Estradiol Tablets, USP) with 0.15 mg/0.02 mg and 0.01 mg dosage. The medication is distributed by Mayne Pharma. However, the provided text also contains some unreadable characters, so some details might be missing.*
FDA Label Image

Image-11 (Image 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.